Michigan Attorney General Bill Schuette sued McKesson, accusing the company of conspiring to artificially inflate the wholesale prices of brand-name drugs – including Lipitor, Zyprexa, Allegra, Celebrex, and Advair – between 2001 and 2009. During this same time period, Michigan Medicaid spent nearly $2 billion on the brandname pharmaceuticals in question, as well as approximately $80 million on the affected generic drugs. The lawsuit alleges that McKesson and pharmaceutical data publishing company First DataBank (owned by Hearst Corporation) conspired to artificially inflate the average wholesale price (AWP) of the drugs, causing the Michigan Medicaid program to overpay pharmacy claims by millions of dollars.